PDB Short entry for 2JED HEADER TRANSFERASE 16-JAN-07 2JED TITLE THE CRYSTAL STRUCTURE OF THE KINASE DOMAIN OF THE PROTEIN KINASE C TITLE 2 THETA IN COMPLEX WITH NVP-XAA228 AT 2.32A RESOLUTION. COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTEIN KINASE C THETA; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: KINASE DOMAIN 361-706; COMPND 5 SYNONYM: NPKC-THETA; COMPND 6 EC: 2.7.11.13; COMPND 7 MUTATION: YES; COMPND 8 OTHER_DETAILS: PHOSPHOSERINE 676, PHOSPHOSERINE 695, C540 MODIFIED SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606 KEYWDS PHOSPHORYLATION, NUCLEOTIDE-BINDING, SERINE/THREONINE-PROTEIN KINASE, KEYWDS 2 TRANSFERASE, ATP-BINDING, POLYMORPHISM, METAL-BINDING, ZINC, KINASE, KEYWDS 3 PKC THETA, MAGNESIUM, ZINC-FINGER, ALTERNATIVE SPLICING, PHORBOL- KEYWDS 4 ESTER BINDING EXPDTA X-RAY DIFFRACTION AUTHOR W.STARK,F.BITSCH,A.BERNER,F.BUELENS,P.GRAFF,H.DEPERSIN,M.GEISER, AUTHOR 2 R.KNECHT,J.RAHUEL,G.RUMMEL,J.M.SCHLAEPPI,R.SCHMITZ,A.STRAUSS, AUTHOR 3 J.WAGNER REVDAT 6 13-DEC-23 2JED 1 REMARK REVDAT 5 25-SEP-19 2JED 1 REMARK REVDAT 4 15-MAY-19 2JED 1 REMARK LINK REVDAT 3 24-FEB-09 2JED 1 VERSN REVDAT 2 19-FEB-08 2JED 1 JRNL REMARK HET HETNAM REVDAT 2 2 1 FORMUL LINK HETATM TER REVDAT 2 3 1 CONECT REVDAT 1 05-FEB-08 2JED 0 JRNL AUTH W.STARK,F.BITSCH,A.BERNER,F.BUELENS,P.GRAFF,H.DEPERSIN, JRNL AUTH 2 G.FENDRICH,M.GEISER,R.KNECHT,J.RAHUEL,G.RUMMEL, JRNL AUTH 3 J.M.SCHLAEPPI,R.SCHMITZ,A.STRAUSS,J.WAGNER JRNL TITL THE CRYSTAL STRUCTURE OF THE KINASE DOMAIN OF THE PROTEIN JRNL TITL 2 KINASE C THETA IN COMPLEX WITH NVP-XAA228 JRNL REF TO BE PUBLISHED JRNL REFN REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH A.STRAUSS,G.FENDRICH,M.A.HORISBERGER,J.LIEBETANZ,B.MEYHACK, REMARK 1 AUTH 2 J.-M.SCHLAEPPI,R.SCHMITZ REMARK 1 TITL IMPROVED EXPRESSION OF KINASES IN BACULOVIRUS-INFECTED REMARK 1 TITL 2 INSECT CELLS UPON ADDITION OF SPECIFIC KINASE INHIBITORS TO REMARK 1 TITL 3 THE CULTURE HELPFUL FOR STRUCTURAL STUDIES. REMARK 1 REF PROTEIN EXPRESSION PURIF. V. 56 167 2007 REMARK 1 REFN ISSN 1046-5928 REMARK 1 PMID 17720535 REMARK 1 DOI 10.1016/J.PEP.2007.06.008 REMARK 2 REMARK 2 RESOLUTION. 2.32 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.32 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.88 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 40693 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.188 REMARK 3 R VALUE (WORKING SET) : 0.186 REMARK 3 FREE R VALUE : 0.221 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2131 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.32 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.38 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2961 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 BIN R VALUE (WORKING SET) : 0.2470 REMARK 3 BIN FREE R VALUE SET COUNT : 134 REMARK 3 BIN FREE R VALUE : 0.3440 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5396 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 76 REMARK 3 SOLVENT ATOMS : 412 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 49.20 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.17000 REMARK 3 B22 (A**2) : -0.17000 REMARK 3 B33 (A**2) : 0.25000 REMARK 3 B12 (A**2) : -0.08000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.257 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.198 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.134 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 10.404 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.955 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.941 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 5624 ; 0.012 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 7582 ; 1.445 ; 1.974 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 645 ; 7.128 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 290 ;34.790 ;24.069 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 1020 ;17.001 ;15.059 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 31 ;17.011 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 768 ; 0.109 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4276 ; 0.005 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 2324 ; 0.198 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 3739 ; 0.303 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 400 ; 0.148 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 56 ; 0.219 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 12 ; 0.233 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 3333 ; 0.734 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 5200 ; 1.222 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2636 ; 1.861 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 2382 ; 2.847 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 2JED COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 16-JAN-07. REMARK 100 THE DEPOSITION ID IS D_1290031107. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 06-SEP-02 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X06SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.918396 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 42831 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.320 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 200 DATA REDUNDANCY : 4.800 REMARK 200 R MERGE (I) : 0.06000 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 10.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.32 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.36 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.48000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 1FOT REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 56.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.14 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: VAPOR DIFFUSION AT 4C PROTEIN REMARK 280 SOLUTION: 10MG/ML PROTEIN IN 0.2M NACL, 0.05M IMIDAZOLE, 0.001M REMARK 280 NAF, 0.05M TCEP, PH = 8.0 RESERVOIR SOLUTION: 0.1 M NA- REMARK 280 CACODYLATE PH = 6.5 24% MPD (V/V) 4% PEG8000 (W/V) DROP: 1:1 REMARK 280 SMALL ORGANIC MOLECULES LIKE 2,5-HEXANEDIOL AND SULFOBETAINE-195 REMARK 280 HAVE A POSITIVE EFFECT ON THE CRYSTAL GROWTH, PH 6.5, REMARK 280 TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 65 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 -X,-Y,Z+1/2 REMARK 290 5555 Y,-X+Y,Z+1/6 REMARK 290 6555 X-Y,X,Z+5/6 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 49.89133 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 24.94567 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 37.41850 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 12.47283 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 62.36417 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 ENGINEERED RESIDUE IN CHAIN A, ILE 381 TO GLU REMARK 400 ENGINEERED RESIDUE IN CHAIN A, THR 538 TO GLU REMARK 400 ENGINEERED RESIDUE IN CHAIN B, ILE 381 TO GLU REMARK 400 ENGINEERED RESIDUE IN CHAIN B, THR 538 TO GLU REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLU A 361 REMARK 465 PRO A 362 REMARK 465 GLU A 363 REMARK 465 LEU A 364 REMARK 465 ASN A 365 REMARK 465 LYS A 366 REMARK 465 GLU A 367 REMARK 465 ARG A 368 REMARK 465 PRO A 369 REMARK 465 SER A 370 REMARK 465 LEU A 371 REMARK 465 GLN A 372 REMARK 465 ILE A 373 REMARK 465 LYS A 374 REMARK 465 MET A 701 REMARK 465 GLU A 702 REMARK 465 ARG A 703 REMARK 465 LEU A 704 REMARK 465 ILE A 705 REMARK 465 SER A 706 REMARK 465 HIS A 707 REMARK 465 HIS A 708 REMARK 465 HIS A 709 REMARK 465 HIS A 710 REMARK 465 HIS A 711 REMARK 465 HIS A 712 REMARK 465 GLU B 361 REMARK 465 PRO B 362 REMARK 465 GLU B 363 REMARK 465 LEU B 364 REMARK 465 ASN B 365 REMARK 465 LYS B 366 REMARK 465 GLU B 367 REMARK 465 ARG B 368 REMARK 465 PRO B 369 REMARK 465 SER B 370 REMARK 465 LEU B 371 REMARK 465 GLN B 372 REMARK 465 ILE B 373 REMARK 465 LYS B 374 REMARK 465 PHE B 659 REMARK 465 ASP B 660 REMARK 465 CYS B 661 REMARK 465 SER B 662 REMARK 465 ASN B 663 REMARK 465 PHE B 664 REMARK 465 ASP B 665 REMARK 465 LYS B 666 REMARK 465 GLU B 667 REMARK 465 PHE B 668 REMARK 465 LEU B 669 REMARK 465 ASN B 670 REMARK 465 GLU B 671 REMARK 465 LYS B 672 REMARK 465 PRO B 673 REMARK 465 HIS B 712 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OH TYR B 545 O HOH B 2114 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 CYS A 540 C GLY A 541 N -0.215 REMARK 500 CYS B 540 CB CYS B 540 SG -0.127 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PHE A 539 O - C - N ANGL. DEV. = -12.3 DEGREES REMARK 500 CYS A 540 C - N - CA ANGL. DEV. = 16.9 DEGREES REMARK 500 LEU B 434 CA - CB - CG ANGL. DEV. = 16.7 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 401 -31.10 168.11 REMARK 500 THR A 402 -21.08 -146.23 REMARK 500 HIS A 474 -52.31 80.87 REMARK 500 ARG A 503 -8.62 69.15 REMARK 500 ASP A 522 92.49 67.55 REMARK 500 MET A 530 54.10 -107.03 REMARK 500 ASN A 557 -148.23 -122.94 REMARK 500 PHE A 614 34.12 -81.54 REMARK 500 ARG A 635 -38.67 -38.44 REMARK 500 ASP A 679 88.55 -69.67 REMARK 500 LYS B 376 -154.90 124.18 REMARK 500 ILE B 377 -45.07 64.65 REMARK 500 THR B 450 -167.06 -114.40 REMARK 500 HIS B 474 -29.93 74.58 REMARK 500 ARG B 503 -12.75 72.97 REMARK 500 ASP B 513 164.72 -47.95 REMARK 500 ASP B 522 89.68 69.71 REMARK 500 MET B 530 40.35 -107.03 REMARK 500 ASN B 557 -148.03 -125.91 REMARK 500 LEU B 675 86.32 51.46 REMARK 500 PHE B 677 -151.46 -135.49 REMARK 500 ALA B 678 95.81 -45.61 REMARK 500 ALA B 681 104.79 69.72 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 LYS A 400 LYS A 401 -52.28 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE LG8 A1701 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE LG8 B1712 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MPD B1713 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1XJD RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF PKC-THETA COMPLEXED WITH STAUROSPORINEAT 2A REMARK 900 RESOLUTION REMARK 999 REMARK 999 SEQUENCE REMARK 999 MUTATIONS I381E, T538E DBREF 2JED A 361 706 UNP Q04759 KPCT_HUMAN 361 706 DBREF 2JED A 707 712 PDB 2JED 2JED 707 712 DBREF 2JED B 361 706 UNP Q04759 KPCT_HUMAN 361 706 DBREF 2JED B 707 712 PDB 2JED 2JED 707 712 SEQADV 2JED GLU A 381 UNP Q04759 ILE 381 ENGINEERED MUTATION SEQADV 2JED GLU A 538 UNP Q04759 THR 538 ENGINEERED MUTATION SEQADV 2JED GLU B 381 UNP Q04759 ILE 381 ENGINEERED MUTATION SEQADV 2JED GLU B 538 UNP Q04759 THR 538 ENGINEERED MUTATION SEQRES 1 A 352 GLU PRO GLU LEU ASN LYS GLU ARG PRO SER LEU GLN ILE SEQRES 2 A 352 LYS LEU LYS ILE GLU ASP PHE GLU LEU HIS LYS MET LEU SEQRES 3 A 352 GLY LYS GLY SER PHE GLY LYS VAL PHE LEU ALA GLU PHE SEQRES 4 A 352 LYS LYS THR ASN GLN PHE PHE ALA ILE LYS ALA LEU LYS SEQRES 5 A 352 LYS ASP VAL VAL LEU MET ASP ASP ASP VAL GLU CYS THR SEQRES 6 A 352 MET VAL GLU LYS ARG VAL LEU SER LEU ALA TRP GLU HIS SEQRES 7 A 352 PRO PHE LEU THR HIS MET PHE CYS THR PHE GLN THR LYS SEQRES 8 A 352 GLU ASN LEU PHE PHE VAL MET GLU TYR LEU ASN GLY GLY SEQRES 9 A 352 ASP LEU MET TYR HIS ILE GLN SER CYS HIS LYS PHE ASP SEQRES 10 A 352 LEU SER ARG ALA THR PHE TYR ALA ALA GLU ILE ILE LEU SEQRES 11 A 352 GLY LEU GLN PHE LEU HIS SER LYS GLY ILE VAL TYR ARG SEQRES 12 A 352 ASP LEU LYS LEU ASP ASN ILE LEU LEU ASP LYS ASP GLY SEQRES 13 A 352 HIS ILE LYS ILE ALA ASP PHE GLY MET CYS LYS GLU ASN SEQRES 14 A 352 MET LEU GLY ASP ALA LYS THR ASN GLU PHE CYS GLY THR SEQRES 15 A 352 PRO ASP TYR ILE ALA PRO GLU ILE LEU LEU GLY GLN LYS SEQRES 16 A 352 TYR ASN HIS SER VAL ASP TRP TRP SER PHE GLY VAL LEU SEQRES 17 A 352 LEU TYR GLU MET LEU ILE GLY GLN SER PRO PHE HIS GLY SEQRES 18 A 352 GLN ASP GLU GLU GLU LEU PHE HIS SER ILE ARG MET ASP SEQRES 19 A 352 ASN PRO PHE TYR PRO ARG TRP LEU GLU LYS GLU ALA LYS SEQRES 20 A 352 ASP LEU LEU VAL LYS LEU PHE VAL ARG GLU PRO GLU LYS SEQRES 21 A 352 ARG LEU GLY VAL ARG GLY ASP ILE ARG GLN HIS PRO LEU SEQRES 22 A 352 PHE ARG GLU ILE ASN TRP GLU GLU LEU GLU ARG LYS GLU SEQRES 23 A 352 ILE ASP PRO PRO PHE ARG PRO LYS VAL LYS SER PRO PHE SEQRES 24 A 352 ASP CYS SER ASN PHE ASP LYS GLU PHE LEU ASN GLU LYS SEQRES 25 A 352 PRO ARG LEU SEP PHE ALA ASP ARG ALA LEU ILE ASN SER SEQRES 26 A 352 MET ASP GLN ASN MET PHE ARG ASN PHE SEP PHE MET ASN SEQRES 27 A 352 PRO GLY MET GLU ARG LEU ILE SER HIS HIS HIS HIS HIS SEQRES 28 A 352 HIS SEQRES 1 B 352 GLU PRO GLU LEU ASN LYS GLU ARG PRO SER LEU GLN ILE SEQRES 2 B 352 LYS LEU LYS ILE GLU ASP PHE GLU LEU HIS LYS MET LEU SEQRES 3 B 352 GLY LYS GLY SER PHE GLY LYS VAL PHE LEU ALA GLU PHE SEQRES 4 B 352 LYS LYS THR ASN GLN PHE PHE ALA ILE LYS ALA LEU LYS SEQRES 5 B 352 LYS ASP VAL VAL LEU MET ASP ASP ASP VAL GLU CYS THR SEQRES 6 B 352 MET VAL GLU LYS ARG VAL LEU SER LEU ALA TRP GLU HIS SEQRES 7 B 352 PRO PHE LEU THR HIS MET PHE CYS THR PHE GLN THR LYS SEQRES 8 B 352 GLU ASN LEU PHE PHE VAL MET GLU TYR LEU ASN GLY GLY SEQRES 9 B 352 ASP LEU MET TYR HIS ILE GLN SER CYS HIS LYS PHE ASP SEQRES 10 B 352 LEU SER ARG ALA THR PHE TYR ALA ALA GLU ILE ILE LEU SEQRES 11 B 352 GLY LEU GLN PHE LEU HIS SER LYS GLY ILE VAL TYR ARG SEQRES 12 B 352 ASP LEU LYS LEU ASP ASN ILE LEU LEU ASP LYS ASP GLY SEQRES 13 B 352 HIS ILE LYS ILE ALA ASP PHE GLY MET CYS LYS GLU ASN SEQRES 14 B 352 MET LEU GLY ASP ALA LYS THR ASN GLU PHE CYS GLY THR SEQRES 15 B 352 PRO ASP TYR ILE ALA PRO GLU ILE LEU LEU GLY GLN LYS SEQRES 16 B 352 TYR ASN HIS SER VAL ASP TRP TRP SER PHE GLY VAL LEU SEQRES 17 B 352 LEU TYR GLU MET LEU ILE GLY GLN SER PRO PHE HIS GLY SEQRES 18 B 352 GLN ASP GLU GLU GLU LEU PHE HIS SER ILE ARG MET ASP SEQRES 19 B 352 ASN PRO PHE TYR PRO ARG TRP LEU GLU LYS GLU ALA LYS SEQRES 20 B 352 ASP LEU LEU VAL LYS LEU PHE VAL ARG GLU PRO GLU LYS SEQRES 21 B 352 ARG LEU GLY VAL ARG GLY ASP ILE ARG GLN HIS PRO LEU SEQRES 22 B 352 PHE ARG GLU ILE ASN TRP GLU GLU LEU GLU ARG LYS GLU SEQRES 23 B 352 ILE ASP PRO PRO PHE ARG PRO LYS VAL LYS SER PRO PHE SEQRES 24 B 352 ASP CYS SER ASN PHE ASP LYS GLU PHE LEU ASN GLU LYS SEQRES 25 B 352 PRO ARG LEU SEP PHE ALA ASP ARG ALA LEU ILE ASN SER SEQRES 26 B 352 MET ASP GLN ASN MET PHE ARG ASN PHE SEP PHE MET ASN SEQRES 27 B 352 PRO GLY MET GLU ARG LEU ILE SER HIS HIS HIS HIS HIS SEQRES 28 B 352 HIS MODRES 2JED SEP A 676 SER PHOSPHOSERINE MODRES 2JED SEP A 695 SER PHOSPHOSERINE MODRES 2JED SEP B 676 SER PHOSPHOSERINE MODRES 2JED SEP B 695 SER PHOSPHOSERINE HET SEP A 676 10 HET SEP A 695 10 HET SEP B 676 10 HET SEP B 695 10 HET LG8 A1701 34 HET LG8 B1712 34 HET MPD B1713 8 HETNAM SEP PHOSPHOSERINE HETNAM LG8 3-(8-DIMETHYLAMINOMETHYL-6,7,8,9-TETRAHYDRO-PYRIDO[1,2- HETNAM 2 LG8 A]INDOL-10-YL)-4-(1-METHYL-1H-INDOL-3-YL)-PYRROLE-2,5- HETNAM 3 LG8 DIONE HETNAM MPD (4S)-2-METHYL-2,4-PENTANEDIOL HETSYN SEP PHOSPHONOSERINE FORMUL 1 SEP 4(C3 H8 N O6 P) FORMUL 3 LG8 2(C28 H28 N4 O2 2+) FORMUL 5 MPD C6 H14 O2 FORMUL 6 HOH *412(H2 O) HELIX 1 1 LYS A 376 GLU A 378 5 3 HELIX 2 2 LYS A 413 ASP A 419 1 7 HELIX 3 3 ASP A 421 SER A 433 1 13 HELIX 4 4 LEU A 434 HIS A 438 5 5 HELIX 5 5 ASP A 465 HIS A 474 1 10 HELIX 6 6 ASP A 477 LYS A 498 1 22 HELIX 7 7 LYS A 506 ASP A 508 5 3 HELIX 8 8 THR A 542 ILE A 546 5 5 HELIX 9 9 ALA A 547 LEU A 552 1 6 HELIX 10 10 HIS A 558 GLY A 575 1 18 HELIX 11 11 ASP A 583 ASP A 594 1 12 HELIX 12 12 GLU A 603 PHE A 614 1 12 HELIX 13 13 GLU A 617 ARG A 621 5 5 HELIX 14 14 ASP A 627 HIS A 631 5 5 HELIX 15 15 HIS A 631 ARG A 635 5 5 HELIX 16 16 ASN A 638 ARG A 644 1 7 HELIX 17 17 ASP A 679 MET A 686 1 8 HELIX 18 18 ASP A 687 ARG A 692 5 6 HELIX 19 19 LYS B 413 ASP B 419 1 7 HELIX 20 20 ASP B 421 SER B 433 1 13 HELIX 21 21 LEU B 434 HIS B 438 5 5 HELIX 22 22 ASP B 465 HIS B 474 1 10 HELIX 23 23 ASP B 477 LYS B 498 1 22 HELIX 24 24 LYS B 506 ASP B 508 5 3 HELIX 25 25 THR B 542 ILE B 546 5 5 HELIX 26 26 ALA B 547 LEU B 552 1 6 HELIX 27 27 HIS B 558 GLY B 575 1 18 HELIX 28 28 ASP B 583 ASP B 594 1 12 HELIX 29 29 GLU B 603 PHE B 614 1 12 HELIX 30 30 GLU B 617 ARG B 621 5 5 HELIX 31 31 ASP B 627 HIS B 631 5 5 HELIX 32 32 HIS B 631 ARG B 635 5 5 HELIX 33 33 ASN B 638 ARG B 644 1 7 HELIX 34 34 ASP B 687 ARG B 692 5 6 HELIX 35 35 ASN B 698 HIS B 708 1 11 SHEET 1 AA 6 PHE A 380 GLY A 389 0 SHEET 2 AA 6 GLY A 392 PHE A 399 -1 O GLY A 392 N GLY A 389 SHEET 3 AA 6 PHE A 405 LYS A 412 -1 O PHE A 406 N ALA A 397 SHEET 4 AA 6 ASN A 453 MET A 458 -1 O LEU A 454 N LEU A 411 SHEET 5 AA 6 MET A 444 GLN A 449 -1 N PHE A 445 O VAL A 457 SHEET 6 AA 6 PHE A 696 MET A 697 -1 O PHE A 696 N THR A 447 SHEET 1 AB 2 ILE A 510 LEU A 512 0 SHEET 2 AB 2 ILE A 518 ILE A 520 -1 O LYS A 519 N LEU A 511 SHEET 1 BA 6 PHE B 380 GLY B 389 0 SHEET 2 BA 6 GLY B 392 PHE B 399 -1 O GLY B 392 N GLY B 389 SHEET 3 BA 6 PHE B 405 LYS B 412 -1 O PHE B 406 N ALA B 397 SHEET 4 BA 6 ASN B 453 GLU B 459 -1 O LEU B 454 N LEU B 411 SHEET 5 BA 6 MET B 444 GLN B 449 -1 N PHE B 445 O VAL B 457 SHEET 6 BA 6 PHE B 696 MET B 697 -1 O PHE B 696 N THR B 447 SHEET 1 BB 2 ILE B 510 LEU B 512 0 SHEET 2 BB 2 ILE B 518 ILE B 520 -1 O LYS B 519 N LEU B 511 LINK C LEU A 675 N SEP A 676 1555 1555 1.33 LINK C SEP A 676 N PHE A 677 1555 1555 1.33 LINK C PHE A 694 N SEP A 695 1555 1555 1.33 LINK C SEP A 695 N PHE A 696 1555 1555 1.33 LINK C LEU B 675 N SEP B 676 1555 1555 1.33 LINK C SEP B 676 N PHE B 677 1555 1555 1.34 LINK C PHE B 694 N SEP B 695 1555 1555 1.33 LINK C SEP B 695 N PHE B 696 1555 1555 1.32 SITE 1 AC1 15 LEU A 386 GLY A 387 PHE A 391 VAL A 394 SITE 2 AC1 15 ALA A 407 GLU A 428 THR A 442 GLU A 459 SITE 3 AC1 15 TYR A 460 LEU A 461 ASP A 465 ASP A 508 SITE 4 AC1 15 ASP A 522 PHE A 664 HOH A2195 SITE 1 AC2 14 LEU B 386 GLY B 387 PHE B 391 VAL B 394 SITE 2 AC2 14 ALA B 407 GLU B 428 THR B 442 MET B 458 SITE 3 AC2 14 GLU B 459 TYR B 460 LEU B 461 ASP B 465 SITE 4 AC2 14 ASP B 508 LEU B 511 SITE 1 AC3 5 PHE A 597 MET B 467 ILE B 470 GLU B 571 SITE 2 AC3 5 GLY B 575 CRYST1 152.172 152.172 74.837 90.00 90.00 120.00 P 65 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.006572 0.003794 0.000000 0.00000 SCALE2 0.000000 0.007588 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013362 0.00000